SCHEMBL21595437

SCHEMBL21595437

C=CCC1CC2(CCCN2C(=O)O)CC1=O

nearest known ligand 0.37

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.37
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21595372 0.82 GRIN2B (0.39) FAAH
SCHEMBL21595458 0.80 ELANE (0.45)
SCHEMBL21595424 0.74 MEN1 (0.34)
SCHEMBL21595440 0.71 ELANE (0.44)
SCHEMBL21595277 0.69 FAAH (0.37) FAAH
SCHEMBL15751177 0.66 SCD (0.33)
SCHEMBL29998084 0.66 HCRTR1 (0.31)
SCHEMBL30893978 0.66 HCRTR1 (0.31)
SCHEMBL5597540 0.64 FAAH (0.51) FAAH
SCHEMBL22409351 0.64 SOS1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3810615-A1 ARGINASE INHIBITORS AND METHODS OF USE Merck Sharp & Dohme Corp. (US) 2021-04-28 EP disclosed
WO-2019245890-A1 ARGINASE INHIBITORS AND METHODS OF USE MERCK SHARP & DOHME CORP. (US) 2019-12-26 WO disclosed